Please try another search
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 million ($2.75 million) and SEK150 million ($16.51 million) with enterprise value SEK50 million ($5.90 million) and SEK250 million ($23.06 million) and sales revenue between €5 million ($5.43 million) and €25 million ($27.18 million) and EBITDA between SEK1 million ($0.11 million) and SEK50 million ($5.50 million). The firm takes minority and majority stake. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Holland Cheng | - | - | Member of Scientific Advisory Board |
Gunnar Kratz | - | - | Member of Scientific Advisory Board |
Karl-Olov Fagerström | - | - | Member of Scientific Advisory Board |
Staffan Nilsson | 74 | - | Member of Scientific Advisory Board |
Torgny H. Svensson | - | - | Member of Scientific Advisory Board |
David Jern | 51 | 2021 | Independent Director |
Lena Söderström | 64 | 2022 | Independent Director |
Otto Ankarcrona | 53 | 2023 | Independent Director |
Malin Enarson | 51 | 2023 | Independent Director |
Karl Tobieson | 50 | 2008 | Chairman |
Anna Torner | 61 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review